Ganite
RxNorm Crosswalk NDC 66657-301

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

The product Ganite (NDC 66657-301) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 2 unique RxNorm concepts. By anchoring Genta Incorporated's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCD
Featured Concept

gallium nitrate 25 MG/ML Injectable Solution
(RxCUI 197734)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SBD
Featured Concept

gallium nitrate 25 MG/ML Injectable Solution [Ganite]
(RxCUI 210238)

Semantic Branded Drug

Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.

Understanding RxNorm Mapping for Ganite

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 66657-301 to RxCUI 197734, 210238, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.

* Please review the full disclaimer at the bottom of this page.